Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,925.35
+3,810.68(+8.09%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Syra Health Corp. (SYRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.4600

+0.2600

(+21.67%)

At close: 04:00PM EDT

1.4997

+0.04

(+2.72%)

After hours:

07:58PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	9.64M
Enterprise value	6.61M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.29
Price/book (mrq)	2.40
Enterprise value/revenue	1.20
Enterprise value/EBITDA	-2.33

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-60.00%
S&P500 52-week change ³	22.38%
52-week high ³	8.3700
52-week low ³	0.8120
50-day moving average ³	1.5017
200-day moving average ³	1.5238

Share statistics

Avg vol (3-month) ³	2.03M
Avg vol (10-day) ³	684.37k
Shares outstanding ⁵	5.77M
Implied shares outstanding ⁶	6.42M
Float ⁸	3.29M
% held by insiders ¹	30.13%
% held by institutions ¹	2.21%
Shares short (15 Apr 2024) ⁴	144.57k
Short ratio (15 Apr 2024) ⁴	1.84
Short % of float (15 Apr 2024) ⁴	N/A
Short % of shares outstanding (15 Apr 2024) ⁴	2.88%
Shares short (prior month 15 Mar 2024) ⁴	142.62k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-53.28%
Operating margin (ttm)	-55.83%

Management effectiveness

Return on assets (ttm)	-49.83%
Return on equity (ttm)	-124.42%

Income statement

Revenue (ttm)	5.52M
Revenue per share (ttm)	1.13
Quarterly revenue growth (yoy)	-10.20%
Gross profit (ttm)	N/A
EBITDA	-2.84M
Net income avi to common (ttm)	-2.94M
Diluted EPS (ttm)	-0.6000
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	3.28M
Total cash per share (mrq)	0.23
Total debt (mrq)	248.1k
Total debt/equity (mrq)	6.18%
Current ratio (mrq)	5.25
Book value per share (mrq)	0.29

Cash flow statement

Operating cash flow (ttm)	-2.76M
Levered free cash flow (ttm)	-1.93M